Rhamnetin 3-sophorosideCAS# 259234-17-8 |
Quality Control & MSDS
Package In Stock
Number of papers citing our products
| Cas No. | 259234-17-8 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C28H32O17 | M.Wt | 640.6 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Rhamnetin 3-sophoroside Dilution Calculator
Rhamnetin 3-sophoroside Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.561 mL | 7.8052 mL | 15.6104 mL | 31.2207 mL | 39.0259 mL |
| 5 mM | 0.3122 mL | 1.561 mL | 3.1221 mL | 6.2441 mL | 7.8052 mL |
| 10 mM | 0.1561 mL | 0.7805 mL | 1.561 mL | 3.1221 mL | 3.9026 mL |
| 50 mM | 0.0312 mL | 0.1561 mL | 0.3122 mL | 0.6244 mL | 0.7805 mL |
| 100 mM | 0.0156 mL | 0.0781 mL | 0.1561 mL | 0.3122 mL | 0.3903 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Rhamnetin 3-O-gentiobioside
Catalog No.:BCX2086
CAS No.:1786990-15-8
- Methyl-6-gingerol
Catalog No.:BCX2085
CAS No.:23513-10-2
- 16-Acetoxy-7alpha-methoxyroyleanone
Catalog No.:BCX2084
CAS No.:109974-33-6
- Fischeroside A
Catalog No.:BCX2083
CAS No.:1307257-07-3
- 2-Hydroxy-6-methoxy-4-O-(6''-O-alpha-L-arabinofuranosyl-beta-D-glucopyranosyl)acetophenone
Catalog No.:BCX2082
CAS No.:1452160-87-0
- Isobiflorin
Catalog No.:BCX2081
CAS No.:152041-16-2
- Bracteanolide A
Catalog No.:BCX2080
CAS No.:1021432-39-2
- Graciliflorin E
Catalog No.:BCX2079
CAS No.:1413941-66-8
- 6,12,15-Trihydroxy-5,8,11,13-abietetra-7-one
Catalog No.:BCX2078
CAS No.:371155-09-8
- Gerardianin B
Catalog No.:BCX2077
CAS No.:2070919-73-0
- 16-Acetoxylsugiol
Catalog No.:BCX2076
CAS No.:1413941-65-7
- Aesculitannin B
Catalog No.:BCX2075
CAS No.:114612-77-0
- Suksdorfin
Catalog No.:BCX2088
CAS No.:53023-17-9
- Notoginsenoside SFt4
Catalog No.:BCX2089
CAS No.:1351360-30-9
- Albanin D
Catalog No.:BCX2090
CAS No.:134955-26-3
- 4'-O-Methylisoliquiritigenin
Catalog No.:BCX2091
CAS No.:476487-22-6
- Rutarin
Catalog No.:BCX2092
CAS No.:20320-81-4
- 5'-Methoxyoctahydrocurcumin
Catalog No.:BCX2093
CAS No.:718638-77-8
- 6-Hydroxykaempferol 7-glucoside
Catalog No.:BCX2094
CAS No.:70056-55-2
- Isosyringalide 3'-rhamnoside
Catalog No.:BCX2095
CAS No.:110326-99-3
- Tupichinol B
Catalog No.:BCX2096
CAS No.:497142-89-9
- Isorutarin
Catalog No.:BCX2097
CAS No.:53846-51-8
- Wattigenin A
Catalog No.:BCX2098
CAS No.:171485-66-8
- 4-(3,5-Dihydroxy-7-(4-hydroxy-3-methoxyphenyl)heptyl)benzene-1,2-diol
Catalog No.:BCX2099
CAS No.:884495-94-7
Evaluating the anti-cancer potential and pharmacological in-sights of Physalis angulata Root Extract as a strong candidate for future research.[Pubmed:39674639]
J Genet Eng Biotechnol. 2024 Dec;22(4):100410.
The research targeting the prevention of complications through natural constituents, instigated by the cancer has recently drawn much more attention over the globe. The research in this direction also revealed that the use of natural constituents would considered a promising strategy for diminishing the aforementioned disease and its consequences. Because of the easy availability and safe nature, the recent years, natural resources as strong anticancer agents. In this regard, here we introduced the possibility of using the methanolic extract of Physalis angulata root as a strong candidate and implemented the applicability of LC-MS to unveil the presence of various phytocompounds. The anticancer potential exhibited by Physalis angulata root followed by its ability to induce toxicity against the microbial population enhanced the interest in unveiling the phytochemical compounds including Absintholide, Curcumin dimer 1, Mytilin A, Ginsenoside F1, Encecalin , Ganoderic acid TQ, Alnustone, Rhamnetin 3-sophoroside, Gibberellin A14 aldehyde, Thiolutin, Euglobal III and Epomusenin B. The presence of various macro and micronutrients suggested that Physalis angulata is a prominent resource for future research targeting pharmacological research, especially anticancer research.
